GeoVax Labs, Inc. (GOVX) › Cash & EquivalentsGeoVax Labs, Inc. (GOVX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $2.19M2009: $3.52M2010: $1.08M2011: $1.17M2012: $1.04M2013: $2.51M2014: $1.10M2015: $1.06M2016: $454.0K2017: $312.7K2018: $259.7K2019: $283.3K2020: $9.88M2021: $11.42M2022: $27.61M2023: $6.45M2024: $5.51M2025: $3.09M$3.09M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$3.09M-44.0%2024$5.51M-14.7%2023$6.45M-76.6%2022$27.61M+141.7%2021$11.42M+15.6%2020$9.88M+3388.3%2019$283.3K+9.1%2018$259.7K-17.0%2017$312.7K-31.1%2016$454.0K-57.2%2015$1.06M-3.7%2014$1.10M-56.2%2013$2.51M+142.7%2012$1.04M-11.3%2011$1.17M+8.2%2010$1.08M-69.3%2009$3.52M+60.5%2008$2.19M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share